Search research articles
Contact Us
Filters
Showing results (391-400 of 524) with videos related to
Page
of 53
Sort By:
JTO Clinical and Research Reports
|
November 13, 2023
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Hye Ryun Kim, Mark M Awad, Alejandro Navarro, et al.
Viruses
|
November 27, 2021
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry
Anh Phuong Luu, Zhenlan Yao, Sangeetha Ramachandran, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer
Alessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2016
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman, Maria C Pietanza, Matthew D Hellmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 24, 2026
Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations rather than Hepatoid Differentiation
Christopher A Febres-Aldana, Chad M Vanderbilt, Rania Aly, et al.
Science (New York, N.Y.)
|
December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
The New England Journal of Medicine
|
June 8, 2012
Efficacy and safety of vismodegib in advanced basal-cell carcinoma
Aleksandar Sekulic, Michael R Migden, Anthony E Oro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Charles M Rudin, Stephen V Liu, Ross A Soo, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
Page
of 53
Search research articles
Search
Showing results (391-400 of 524) with videos related to
Sort By:
Page
of 53
JTO Clinical and Research Reports
|
November 13, 2023
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Hye Ryun Kim, Mark M Awad, Alejandro Navarro, et al.
Viruses
|
November 27, 2021
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry
Anh Phuong Luu, Zhenlan Yao, Sangeetha Ramachandran, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer
Alessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2016
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman, Maria C Pietanza, Matthew D Hellmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 24, 2026
Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations rather than Hepatoid Differentiation
Christopher A Febres-Aldana, Chad M Vanderbilt, Rania Aly, et al.
Science (New York, N.Y.)
|
December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
The New England Journal of Medicine
|
June 8, 2012
Efficacy and safety of vismodegib in advanced basal-cell carcinoma
Aleksandar Sekulic, Michael R Migden, Anthony E Oro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Charles M Rudin, Stephen V Liu, Ross A Soo, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
Page
of 53